Estimating R&D Returns In Health Care Industry

• Autorzy: Waldemar Karpa , Jakub Nowakowski
• Języki publikacji: EN

Abstrakty

EN

Purpose: This paper provides an empirical evaluation of R&D returns for a series of global companies who lead in innovation within the health care industry.

Methodology: The estimation procedure bases on two specifications: the parametric production function setting, and finite distributed lag model (FDL).

Findings: Using the most recent data on R&D investment by health care equipment and services along pharmaceuticals and biotechnology companies, we confirm the positive albeit mitigated impact of R&D efforts on performance indicators (levels of sales). Moreover, we comment on the current phenomena observed in health care industry and offer a policy view for ongoing and future challenges in the sector.

Added value: Since there is a dearth of recent empirical evidence on R&D returns in the broad health industry, this paper offers the evaluation of economic incentives for companies to invest in R&D. These incentives embrace the induced increase in sales and profits levels. The authors participate in a public debate concerning the optimal levels of R&D rewards required to sustain the innovation within the sector. (original abstract)

Słowa kluczowe

PL

Polityka badawczo-rozwojowa; Innowacje; Polityka przemysłowa; Polityka zdrowotna

EN

R&D policy; Innovations; Industrial policy; Health care policy

• Czasopismo: Journal of Management and Business Administration. Central Europe
• Rocznik: 2018
• Tom: 26
• Numer: nr 2
• Strony: 34-46

Twórcy

autor

Waldemar Karpa

• Kozminski University, Warsaw, Poland

autor

Jakub Nowakowski

• Kozminski University, Warsaw, Poland, PhD candidate

Bibliografia

• Al-Horani, A., Pope, P.F. and Stark, A.W. (2003). Research and development activity and expected returns in the United Kingdom. European Finance Review, 7: 27-46, https://doi.org/10.1023/A:1022504029943
• Arrow, K. (1962). Economic welfare and the allocation of resources for invention. In The rate and direction of inventive activity: Economic and social factors. Princeton: Princeton University Press, https://doi.org/10.1515/9781400879762-024
• Artz, Kendall W. et al. (2005). A longitudinal study of the impact of R&D, patents, and product innovation on firm performance, Journal of Product Innovation Management, 27(5): 725-740, https://doi.org/10.1111/j.1540-5885.2010.00747.x
• Aw, B.Y., Roberts, M.J. and Yi Xu, D. (2011). R&D investment, exporting, and productivity dynamics. The American Economic Review, 101(4): 1312-1344, https://doi.org/10.1257/aer.101.4.1312
• Ballester, M., Garcia-Ayuso, M. and Livnat, J. (2003). The economic value of the R&D intangible asset. European Accounting Review, 12(4): 605-633, https://doi.org/10.1080/09638180310001628437
• Barth, M., Kasznik, R. and McNichols, M. (2001). Analyst coverage and intangible assets. Journal of Accounting Research, 39(1): 1-34, https://doi.org/10.1111/1475-679X.00001
• Berndt, E.R., Nass, D., Kleinrock, M. and Aitken, M. (2015). Decline in economic returns from new drugs raises questions about sustaining innovations. Health Affairs, 34(2): 245-252, https://doi.org/10.1377/hlthaff.2014.1029
• Bilbao-Osorio, Be-at and Rodríguez-Pose, A. (2004). From R&D to innovation and economic growth in the EU. Growth and Change, 35(4): 434-455, https://doi.org/10.1111/j.1468-2257.2004.00256.x
• Bloom, N., Schankerman, M. and Van Reenen, J. (2013). Identifying technology spillovers and product market rivalry. Econometrica, 81(4): 1347-1393, https://doi.org/10.3982/ECTA9466
• Blundell, R., Griffith, R. and Van Reenen, J. (1999). Market share, market value and innovation in a panel of British manufacturing firms. The Review of Economic Studies, 66(3): 529-554, https://doi.org/10.1111/1467-937X.00097
• Bogliacino, F. and Vivarelli, M. (2012). The job creation effect of R&D expenditures, Australian Economic Papers, 51(2): 96-113.
• Bosworth, D. and Rogers, M. (2001). Market value, R&D and intellectual property: an empirical analysis of large Australian firms. Economic Record, 77(239): 323-337, https://doi.org/10.1111/1475-4932.t01-1-00026
• Bowonder, B. et al. (2010). Innovation strategies for creating competitive advantage. Research-technology management, 53(3): 19-32, https://doi.org/10.1080/08956308.2010.11657628
• Canibano, L., Garcia-Ayuso, M. and Sanchez, P. (2000). Accounting for intangibles: a literature review, Journal of Accounting Literature, 19: 102-130.
• Chambers, D., Ross, J. and Thompson, R.B. (2002). Excess returns to R&D-intensive firms, Review of Accounting Studies, 7(2): 133-158, https://doi.org/10.1023/A:1020217817156
• Cockburn, I.M. and Griliches, Z. (1988). Industry effects and appropriability measures in the stock markets valuation of R&D and patents. The American Economic Review, 78(2): 419-423.
• Deloitte (2014). Measuring the return from pharmaceutical innovation 2014: Turning the corner? Deloitte Centre for Health Solutions.
• García-Manjón, J.V. and Romero-Merino, M.E. (2012). Research, development, and firm growth. Empirical evidence from European top R&D spending firms. Research Policy, 41(6): 1084-1092.
• Doraszelski, U. and Jaumandreu, J. (2013). R&D and productivity: Estimating endogenous productivity. The Review of Economic Studies, 80(4): 1338-1383, https://doi.org/10.1093/restud/rdt011
• Fleming, J.J. (2015). The decline of venture capital investment in early-stage life sciences poses a challenge to continued innovation. Health Affairs, 34(2): 271-276, https://doi.org/10.1377/hlthaff.2014.1051
• Griliches, Z. (1979). Issues in assessing the contribution of research and development to productivity growth. The Bell Journal of Economics, 10(1): 92-116, https://doi.org/10.2307/3003321
• Griliches, Z. (1981). Market value, R&D, and patents. Economics Letters, 7(2): 183-187, https://doi.org/10.1016/0165-1765(87)90114-5
• Griliches, Z. (1986). Productivity, R&D, and Basic Research at the Firm Level in the 1970's. American Economic Review, 76(1): 141-154.
• Griliches, Z. (1998). Market value, R&D, and patents. Economics letters, 7(2): 183-187, https://doi.org/10.1016/0165-1765(87)90114-5
• Hall, B.H. (1993). The stock market's valuation of R&D investment during the 1980's. The American Economic Review, 83(2): 259-264.
• Hall, B.H. and Oriani, R. (2006). Does the market value R&D investment by European firms? Evidence from a panel of manufacturing firms in France, Germany, and Italy. International Journal of Industrial Organization, 24(5): 971-993, https://doi.org/10.1016/j.ijindorg.2005.12.001
• Hall, H.B. and Mairesse, J. (2009). Measuring corporate R&D returns. Presentation to the Knowledge for Growth Expert Group, Directorate General for Research, European Commission, Brussels, January.
• Harhoff, D. (1998). R&D and Productivity in German Manufacturing Firms. Economics of Innovation and New Technology, 6(1): 29-50, https://doi.org/10.1080/10438599800000012
• Health Affairs (2015). Biomedical innovation, 34(2): 193-360.
• Hitt, M.A. et al. (1991). Effects of acquisitions on R&D inputs and outputs. Academy of Management Journal, 34(3): 693-706.
• Hsieh, Ping-Hung, Mishra, Ch.S. and Gobeli, D.H. (2003). The return on R&D versus capital expenditures in pharmaceutical and chemical industries. IEEE Transactions on Engineering Management, 50(2): 141-150, https://doi.org/10.1109/TEM.2003.810828
• JRC (2015). The 2015 EU Industrial R&D Investment Scoreboard. Publication Office of the European Union, Luxembourg. doi:10.2791/15792
• Lai, Ming-Fong, and Gwo-Guang Lee (2007). Risk-avoiding cultures toward achievement of knowledge sharing. Business Process Management Journal, 13(4): 522-537, https://doi.org/10.1108/14637150710763559
• Li, Dongmei (2011). Financial constraints, R&D investment, and stock returns. Review of Financial Studies, 24(9): 2974-3007, https://doi.org/10.1093/rfs/hhr043
• Lichtenberg, F.R. (1992). R&D investment and international productivity differences, 4161, National Bureau of Economic Research, https://doi.org/10.3386/w4161
• Lichtenberg, F.R. (2003). The economic and human impact of new drugs. The Journal of Clinical Psychiatry, 64(suppl 17): 15-18.
• Lichtenberg, F.R. and Siegel, D. (1991). The impact of R&D investment on productivity-New evidence using linked R&D-LRD data. Economic Inquiry, 29(2): 203-229, https://doi.org/10.1111/j.1465-7295.1991.tb01267.x
• Mairesse, J. and Sassenou, M. (1991). R&D and Productivity: A Survey of Econometric Studies at the Firm Level. Science-Technology-Industry Review, 8: 317-348.
• Mairesse, J. and Mohnen, P. (2005). The importance of R&D for innovation: a reassessment using French survey data. Springer US, https://doi.org/10.1007/0-387-25022-0_10
• Milbergs, E. and Vonortas, N. (2004). Innovation metrics: Measurement to insight. Center for Accelerating Innovation and George Washington University, National Innovation, Initiative 21st Century Working Group 22.
• Morbey, G.K. and Reithner, R.M. (1990). How R&D affects sales growth, productivity and profitability. Research-Technology Management, 33(3): 11-14, https://doi.org/10.1080/08956308.1990.11670656
• Nagaoka, S. (2006). R&D and market value of Japanese firms in the 1990s. Journal of the Japanese and International Economies, 20(2): 155-176, https://doi.org/10.1016/j.jjie.2005.07.001
• Nissim, D. and Thomas, J. (2000). R&D costs and accounting profits. University of Haifa, Zimmerman Foundation Discussion Paper ZF-01-01.
• Paul, S.M., Mytelka, D.S., Dunwiddie, C.T., Persinger, C.C., Munos, B.H., Lindborg, S.R. and Schacht, A.L. (2010). How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nature Reviews Drug discovery, 9(3): 203-214, https://doi.org/10.1038/nrd3078
• Sougiannis, T. (1994). The Accounting Based Valuation of Corporate R&D. The Accounting Review, 69(1): 44-68.
• Thomson-Reuters (2016). Disruptive, game-changing innovation. 2016 State of Innovation. Reuters.
• Toivanen, O., Stoneman, P. and Bosworth, D. (2002). Innovation and the market value of UK firms, 1989-1995. Oxford Bulletin of Economics and Statistics, 64(1): 39-61, https://doi.org/10.1111/1468-0084.00002
• Tubbs, M. (2007). The relationship between R&D and company performance. Research-Technology Management, 50(6): 23-30, https://doi.org/10.1080/08956308.2007.11657470
• Wang, J. and Chung-Yu Yang (2012). Flexibility planning for managing R&D projects under risk. International Journal of Production Economics, 135(2): 823-831, https://doi.org/10.1016/j.ijpe.2011.10.020
• Yunkui, Xue and Wang Zhitai (2001). The Importance of R&D and the Improvement of Its Disclosure. Accounting Research, 3.

Identyfikatory

DOI

10.7206/jmba.ce.2450-7814.227